Short Interest in PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Drops By 25.6%

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 55,000 shares, a decrease of 25.6% from the January 15th total of 73,900 shares. Based on an average trading volume of 157,400 shares, the short-interest ratio is currently 0.3 days.

PreveCeutical Medical Trading Down 2.9 %

PRVCF traded down $0.00 during trading on Friday, hitting $0.02. The company had a trading volume of 200 shares, compared to its average volume of 218,093. The business has a 50-day moving average of $0.02 and a 200-day moving average of $0.02. PreveCeutical Medical has a 1-year low of $0.01 and a 1-year high of $0.03.

About PreveCeutical Medical

PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity.